切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2007, Vol. 01 ›› Issue (05) : 137 -141. doi: 10.3877/cma.j.issn.1674-0807.2007.05.004

临床研究

乳腺癌前哨淋巴结微转移检测研究
范蕾1, 穆殿斌1, 高彦1, 仲伟霞1, 王春建1, 王永胜1,()   
  1. 1.250117 济南,山东省肿瘤医院乳腺病中心
  • 收稿日期:2007-09-07 出版日期:2007-10-01
  • 通信作者: 王永胜

Study on detection of micrometastasis of sentinel lymph node in breast cancer

Lei FAN1, Dian-bin MU1, Yan GAO1, Wei-xia ZHONG1, Chun-jian WANG1, Yong-sheng WANG,1()   

  1. 1.Breast Disease Center, Tumor Hospital of Shandong Province, Jinan 250117, China
  • Received:2007-09-07 Published:2007-10-01
  • Corresponding author: Yong-sheng WANG
引用本文:

范蕾, 穆殿斌, 高彦, 仲伟霞, 王春建, 王永胜. 乳腺癌前哨淋巴结微转移检测研究[J/OL]. 中华乳腺病杂志(电子版), 2007, 01(05): 137-141.

Lei FAN, Dian-bin MU, Yan GAO, Wei-xia ZHONG, Chun-jian WANG, Yong-sheng WANG. Study on detection of micrometastasis of sentinel lymph node in breast cancer[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2007, 01(05): 137-141.

目的

探讨更为合理的乳腺癌前哨淋巴结(sentinel lymph node,SLN)微转移(micrometastasis,MMs)的病理检测方法和临床意义。

方法

对50例常规病理证实阴性的109枚SLN以100 μm间距行多层切片(step section,SS),给予HE染色及广谱细胞角蛋白单抗AE1/AE3免疫组化(immunohistochemical,IHC)检测,比较不同的检测方法。

结果

50 例SLN通过SS-HE法和联合IHC法检测分别检出新的转移灶13 例和17 例,阳性检出率分别提高26%和34% ;联合IHC新增SLN阳性检出4 例,提高检出率8% ( P﹥0.05);全部1166 层切片中,SS病理检测出阳性层面57 层(4.9% ),联合IHC新增阳性层面28层(2.4% )( P﹤0.05);按100、200、300、400、500 μm不同间距进行SS对MMs的检出率分别是26% 、20% 、20% 、16% 、14% ;联合IHC 不同间距对MMs 的检出率分别是34% 、32% 、30% 、32% 、30% 。

结论

SS检测对于微小病灶的检出具有显著优势,联合IHC显著提高阳性层数的检出,但对SLN检出率的提高的差异无统计学意义。 按100、200、300、400、500 μm不同间距进行SS对MMs的检出率无统计学差异。

Objective

To explore a more rational pathological detection method for micrometastasis of sentinel lymph nodes ( SLNs) and its clinical significance.

Methods

Fifty women with breast cancer were included.109 SLNs of the 50 patients were identified negative by standard hematoxylin and eosin (HE) staining examination carried out on initial levels.All SLNs were step sectioned (SS) atl00μm interval and for each level both HE stain examination and immunohistochemical detection with AE1/AE3 were performed.Then different detection methods were analyzed.

Results

In the 50 negative SLN patients, 13 and 17 cases were upstaged in node status by using SS-HE method and combined IHC method separately, therefore the positive detecting rate was increased by 26% and 34% , respectively.Four cases were upstaged in node status via using SS combined with IHC method, the positive detecting rate was increased by 8% (P﹥0.05).In all 1166 slides, 57 slides (4.9% ) were abnormal by SS, and 28 (2.4% ) slides were abnormal by SS combined with IHC ( P﹤0.05).The rate of detection of MMs in 100-, 200-, 300-,400-, and 500 μm intervals was 26% ,20% , 20% , 16% , and 14% by SS with HE stain respectively, and 34% , 32% , 30% , 32% , and 30% by the method of SS combined with IHC.

Conclusions

SS could significantly increase the detection of occult tumor deposits in negative SLN with routinely histological exam; IHC could increase the detection of abnormal slides; SS in different intervals does not add significance.

表1 50 例SLN阴性乳腺癌患者的临床及病理情况总结
表2 微转移检测阳性患者的临床及病理情况总结
表3 不同间距阳性切片的检出率
表4 不同间距MMs 检出率
[1]
Gary H L, Armando E G,Mark R.American Society of Clinical Oncology Guideline Recommendations for sentinel lymph node biopsy in early-stage breast cancer.J Clin Oncol,2005,23:7703 -7720.
[2]
Greene F L, Page D I, Fleming I D,et al.AJCC Cancer Staging Manual, 6th Edition.New York:Springer,2002:255 -281.
[3]
Reynolds C, Mick R, Donohue J H, et al.Sentinel lymph node biopsy with metastasis:Can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol,1999,17:1720-1726.
[4]
Morrow M.Is axillary dissection necessary after positive sentinel node biopsy? Ann Surg Oncol,2001,8:74S-76S.
[5]
Fournier K, Schiller A, Perry R R,et al .Micrometastasis in the sentinel lymph node of breast cancer does not mandate completion axillary dissection.Ann Surg,2004,239:859 -863.
[6]
Weaver D L.Sentinel lymph nodes and breast carcinoma:which micrometastases are clinically significant? Am J Surg Pathol,2003,27:842 -845.
[7]
Csemi G, Amendoeira L A N, Bellocq J P.Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer:results of a questionnaire based survey by the European Working Group for Breast Screening Pathology.J Clin Pathol,2004,57:695 -701.
[8]
Cserni G.A model for determining the optimum histology of sentinel lymph nodes in breast cancer.J Clin Pathol,2004,57:467 - 471.
[9]
Cummings M C, Walsh M D, Hohn B G, et al .Occult axillary lymph node metastases in breast cancer do matter:results of 10 - year survival analysis.Am J Surg Pathol, 2002, 26:1286 - 1295.
[10]
Quan M L, Cody H S Ⅲ.Missed micrometastatic disease in breast cancer.Semin Oncol,2004,31:311 -317.
[11]
Guenther J M, Hansen N M, DiFronzo L A, et al.Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes.Arch Surg,2003,138:52 -56.
[12]
Weaver D L.Sentinel lymph node biopsy in breast cancer:creating controversy and defining new standards.Adv Anat Pathol,2001,8:65 -73.
[13]
Falconieri G, Pizzolitto S, Gentile G.Comprehensive examination of sentinel lymph node in breast cancer:a solution without a problem? Int J Surg Pathol,2006,14:1 -8.
[14]
Rivera M, Merlin S, Hoda R, et al.Minimal involvement of sentinel lymph node in breast carcinoma:prevailing concepts and challenging problems.Int J Surg Pathol,2004,12:301 -306.
[15]
Cserni G, Weaver D L.Expert opinion:evaluation of sentinel lymph nodes in breast cancer.Histopathology,2005,46:697 -706.
[16]
Cote R, Peterson H, Chaiwun B,et al .Role of immunohistochemical detection of lymph-node metastases in management of breast cancer.Lancet,1999,354:896 -900.
[17]
Querzoli P, Pedriali M, Rinaldi R,et al.Axillary lymph node nanometastases are prognostic factors for metastatic relapse in breast cancer patients.Clin Cancer Res,2006,15,12:6696 -6701.
[18]
Cserni G, Bianchi S, Boecker W,et al.Improving the reproducibility of diagnosing micrometastases and isolated tumor cells.Cancer,2005,103:358 -367.
[19]
Steidn gtluemtaoryr Sce Ells, :Gcrleaerinfeic Fat iLon, Sofo bthine L6 tHh .e dCitliaosns ifoifc athtieo nA omf eirsioclaan-Joint Committee on Cancer Staging Manual.Cancer,2003,98:2 7 4 0 - 2 7 4 1 .
[20]
Kristine E C, Nora M H, Roderick R T, et al .Nonsentinel node metastases in breast cancer patients with isolated tumor cells in the sentinel node:implications for completion axillary node dissection.Am J Surg,2005,190:588 -591.
[21]
Kuehn T, Bembenek A, Decker T, et al .Consensus Committee of the German Society of Senology.A concept for the clinical implementation of sentinel lymph node biopsy in patients with breast carcinoma with special regard to quality assurance.Cancer,2005,103:451 -461.
[22]
Cserni G, Amendoeira I, Apostolikas N,et al.Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer:results of a questionnaire based survey by the European Working Group for Breast Screening Pathology.J Clin Pathol,2004,57:695 -701.
[1] 洪玮, 叶细容, 刘枝红, 杨银凤, 吕志红. 超声影像组学联合临床病理特征预测乳腺癌新辅助化疗完全病理缓解的价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 571-579.
[2] 刘伟, 牛云峰, 安杰. LINC01232 通过miR-516a-5p/BCL9 轴促进三阴性乳腺癌的恶性进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 330-338.
[3] 杨柳, 宋振川, 王新乐. 乳腺癌改良根治术联合背阔肌复位的临床疗效评估[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(05): 269-273.
[4] 张钊, 骆成玉, 张树琦, 何平, 李旭斌. 不同术式治疗早期乳腺癌的效果及并发症发生率、复发率比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 494-497.
[5] 宋佳, 汪波, 孙凯律, 商江峰, 吴旦平, 肇毅. 吲哚菁绿荧光显影联合亚甲蓝染色在乳腺癌前哨淋巴结活检中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 498-501.
[6] 孙建娜, 孔令军, 任崇禧, 穆坤, 王晓蕊. 266例首诊Ⅳ期乳腺癌手术患者预后分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 502-505.
[7] 唐丹萍, 王萍, 江孟蝶, 杨晓蓉. 自体脂肪移植在乳腺癌术后乳房重建的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 582-585.
[8] 胡宁宁, 赵延荣, 王栋, 王胜亮, 郭源. FMNL3与肝细胞癌肝移植受者预后的相关性研究[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 283-288.
[9] 司钦亮, 毕世龙, 焦慧骁, 李世照, 陈哲禹, 武玉东. 精索去分化脂肪肉瘤两例并文献复习[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 585-590.
[10] 黄程鑫, 陈莉, 刘伊楚, 王水良, 赖晓凤. OPA1 在乳腺癌组织的表达特征及在ER阳性乳腺癌细胞中的生物学功能研究[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(05): 275-284.
[11] 刘琦, 王守凯, 王帅, 苏雨晴, 马壮, 陈海军, 司丕蕾. 乳腺癌肿瘤内微生物组的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 841-845.
[12] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
[13] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
[14] 王帅, 张志远, 苏雨晴, 李雯雯, 王守凯, 刘琦, 李文涛. 孟德尔随机化及其在乳腺癌研究中的应用进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 671-676.
[15] 张梦婷, 穷拉姆, 色珍, 李逸群, 德庆旺姆. 西藏地区藏族乳腺癌新辅助化疗的真实世界研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 441-446.
阅读次数
全文


摘要